Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. The company is headquartered in Abbott Park, Illinois and currently employs 114,000 full-time employees. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. The company serves people in more than 160 countries.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
03/31/2026
12/31/2025
09/30/2025
06/30/2025
03/31/2025
Revenue
45,134
11,164
11,459
11,369
11,142
10,358
Revenue Growth (YoY)
7%
8%
4%
7%
7%
4%
Cost of Revenue
19,635
4,880
4,913
5,044
4,798
4,455
Gross Profit
25,499
6,284
6,546
6,325
6,344
5,903
Selling, General & Admin
12,434
3,267
3,076
3,007
3,084
3,053
Research & Development
2,929
743
720
748
718
703
Operating Expenses
17,047
4,432
4,218
4,175
4,222
4,176
Other Non Operating Income (Expenses)
573
152
134
150
137
127
Pretax Income
8,137
1,449
2,358
2,180
2,150
1,778
Income Tax Expense
1,861
372
582
536
371
453
Net Income
6,276
1,077
1,776
1,644
1,779
1,325
Net Income Growth
-54%
-19%
-81%
0%
37%
8%
Shares Outstanding (Diluted)
1,747
1,747
1,744.51
1,749.36
1,750.83
1,747.22
Shares Change (YoY)
0%
0%
0%
0%
0%
0%
EPS (Diluted)
3.6
0.62
1.02
0.94
1.02
0.76
EPS Growth
-53%
-18%
-81%
0%
38%
9%
Free Cash Flow
7,378
916
2,626
2,291
1,545
933
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
56.49%
56.28%
57.12%
55.63%
56.93%
56.98%
Operating Margin
18.72%
16.58%
20.31%
18.91%
19.04%
16.67%
Profit Margin
13.9%
9.64%
15.49%
14.46%
15.96%
12.79%
Free Cash Flow Margin
16.34%
8.2%
22.91%
20.15%
13.86%
9%
EBITDA
11,615
2,655
3,120
2,941
2,899
2,483
EBITDA Margin
25.73%
23.78%
27.22%
25.86%
26.01%
23.97%
D&A For EBITDA
3,163
803
792
791
777
756
EBIT
8,452
1,852
2,328
2,150
2,122
1,727
EBIT Margin
18.72%
16.58%
20.31%
18.91%
19.04%
16.67%
Effective Tax Rate
22.87%
25.67%
24.68%
24.58%
17.25%
25.47%
Follow-Up Questions
What are Abbott Laboratories's key financial statements?
According to the latest financial statement (Form-10K), Abbott Laboratories has a total asset of $0, Net loss of $0
What are the key financial ratios for ABT?
Abbott Laboratories's Current ratio is 0, has a Net margin is 0, sales per share of $0.
How is Abbott Laboratories's revenue broken down by segment or geography?
Abbott Laboratories largest revenue segment is Established Pharmaceutical Products, at a revenue of 5,536,000,000 in the most earnings release.For geography, United States is the primary market for Abbott Laboratories, at a revenue of 17,126,000,000.
Is Abbott Laboratories profitable?
no, according to the latest financial statements, Abbott Laboratories has a net loss of $0
Does Abbott Laboratories have any liabilities?
no, Abbott Laboratories has liability of 0
How many outstanding shares for Abbott Laboratories?
Abbott Laboratories has a total outstanding shares of 0